TRLV — Trulieve Cannabis Corp. stock price, charts and financials

QT75Trulieve Cannabis Corp.

Trulieve Cannabis Corp. (NYSE: TRLV) is a Healthcare company in the Medical - Pharmaceuticals industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
8.93
+0.18+2.06%
TRLVQT75Trulieve Cannabis Corp.·NYSE
8.93+2.06%
Earnings
Up 2.1% — Reported earnings — EPS beat by 171%, revenue in line.
High confidence
TA
Loading chart...
Signal & projected range
Gap down — mean-reversionHistorical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Premium shows the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands ofhistorical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
Snapshot
Index-P/E-EPS (ttm)-0.42Insider Own1.79%Shs Outstand169.90MPerf Week1.16%
Market Cap1.97BForward P/E23.54EPS next Y0.37Insider Trans-55.92%Shs Float162.36MPerf Month-1.02%
Enterprise Value2.24BPEG-EPS next Q-Inst Own-Short Float1.07%Perf Quarter-6.02%
Income-72.18MP/S1.68EPS this Y140.62%Inst Trans-Short Ratio1.61Perf Half Y27.92%
Sales1.17BP/B1.91EPS next Y117.90%ROA-2.94%Short Interest1.74MPerf YTD0.69%
Book/sh-P/C8.02EPS next 5Y28.83%ROE-6.88%52W High13.55 -34.11%Perf Year65.72%
Cash/sh-P/FCF8.29EPS past 3/5Y-ROIC-5.03%52W Low4.72 89.39%Perf 3Y113.41%
Dividend Est.-EV/EBITDA6.91Sales past 3/5Y-Gross Margin54.60%Volatility5.68% 6.05%Perf 5Y-73.24%
Dividend TTM-EV/Sales1.92EPS Y/Y TTM-Oper. Margin13.57%ATR (14)0.60Perf 10Y-
Dividend Ex-Date-Quick Ratio3.31Sales Y/Y TTM-Profit Margin-6.99%RSI (14)49.75Recom2.00
Dividend Gr. 3/5Y-Current Ratio5.26EPS Q/Q105.88%SMA201.24%Beta1.70Target Price15.00
Payout0.00%Debt/Eq0.54Sales Q/Q-SMA50-5.67%Rel Volume0.94Prev Close8.75
Employees5,000LT Debt/Eq0.47EarningsAug 06SMA20013.50%Avg Volume1.11MPrice8.93
IPO DateSep 25, 2018Option/ShortYes / YesEPS/Sales Surpr.170.80% 0.74%Net Debt/EBITDA0.85Volume1,039,192Change2.06%
Analyst Ratings
DateActionAnalystRatingTarget
Jul-20-26InitiatedCantor FitzgeraldOverweight$15
Latest News
Aug-07-26
Aug-06-26
Aug-05-26
Jul-30-26
Jul-20-26
Jul-16-26
Jul-10-26
Jul-09-26
Jul-01-26
Jun-27-26
Jun-26-26
Company

Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
FY 2025
12/31/2025
Total Revenue1,1391,181
Cost of Goods Sold Incl. D&A462470
Gross Profit677711
Selling, General and Administrative Excl. Other432445
Research and Development
00
Other Operating Expense89118
Operating Income-276148
Interest Expense3163
Unusual Expense
Non-Operating Income (Expense)-217
Net Income Before Taxes-32691
Income Taxes145208
Consolidated Net Income-474-116
Net Income From Continuing Operations-472-117
Net Income-474-116
EPS (Recurring)-2.46-0.61
EPS (Basic, Before Extraordinaries)-2.46-0.61
EPS (Diluted)-2.46-0.61
EBITDA-139328
Other After Tax Adjustments
Stock Option Compensation Expense
Price To Earnings Ratio
Price To Sales Ratio1.511.41
Gross Margin59.4460.20
Operating Margin-24.2312.53
Net Margin-41.62-9.82
Shares Outstanding193191
Market Capitalization1,7231,660
Operating Lease Expense
Insider Trading Volume
$14.46$11.30$8.13$4.97$1.81 Close Price0.00M3.67M7.33M11.00M14.66MUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Rivers Kim A.Chairman and CEOJun 26 '26Sale8.76136,8111,197,9171,476,913Jun 26
Rivers Kim A.Chairman and CEOJun 25 '26Sale8.17300,0002,450,7001,613,724Jun 25
Rivers Kim A.Chairman and CEOJun 24 '26Sale8.17400,0003,267,6001,913,724Jun 25
Rivers Kim A.Chairman and CEOJun 23 '26Sale8.47380,0003,218,2202,313,724Jun 25
Rivers Kim A.Chairman and CEOJun 22 '26Sale9.35204,8151,915,8402,693,724Jun 22
Rivers Kim A.Chairman and CEOJun 18 '26Sale9.46139,8461,322,9432,898,539Jun 22
Rivers Kim A.Chairman and CEOJun 17 '26Sale9.36137,5351,287,1903,038,385Jun 22
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.